Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F7 | P08709 | 1/20 | 0.85 |
| ▸ | F3 | P13726 | 1/20 | 0.85 |
| ▸ | SARM1 | Q6SZW1 | 1/20 | 0.85 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.85 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.85 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.85 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.85 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.85 |
| ▸ | SIRT4 | Q9Y6E7 | 1/20 | 0.85 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.81 |
| ▸ | APP | P05067 | 1/20 | 0.81 |
| ▸ | GAA | P10253 | 1/20 | 0.81 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.81 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.81 |
| ▸ | MKNK1 | Q9BUB5 | 4/20 | 0.56 |
| ▸ | MKNK2 | Q9HBH9 | 4/20 | 0.56 |
| ▸ | KMO | O15229 | 1/20 | 0.54 |
| ▸ | PLOD2 | O00469 | 1/20 | 0.53 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.52 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Niacinamide SCHEMBL28589259 | 0.94 | F7 (0.81) | F7F3SARM1SIRT2SIRT6 | |
| Niacinamide SCHEMBL29596610 | 0.94 | F7 (0.81) | F7F3SARM1SIRT2SIRT6 | |
| Niacin SCHEMBL1640446 | 0.94 | ALDH1A1 (0.91) | F7F3SARM1SIRT2SIRT6 | |
| Niacinamide SCHEMBL675207 | 0.94 | F7 (0.96) | F7F3SARM1SIRT2SIRT6 | |
| Terephthalamic Acid SCHEMBL7674497 | 0.93 | F7 (0.79) | F7F3SARM1SIRT2SIRT6 | |
| Niacinamide SCHEMBL460466 | 0.92 | F7 (1.00) | F7F3SARM1SIRT2SIRT6 | |
| Niacinamide SCHEMBL29624874 | 0.92 | — | — | |
| Niacinamide SCHEMBL19978192 | 0.92 | — | — | |
| Niacinamide SCHEMBL2926 | 0.92 | — | — | |
| Niacinamide SCHEMBL18938563 | 0.91 | F7 (0.76) | F7F3SARM1SIRT2SIRT6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112114060-A | Method for detecting vitamins in formula food with special medical application | 特康药业集团有限公司 | 2020-12-22 | — | — | CN | claimed |
| US-7666451-B2 | Method of treating dyshidrosis(pompholyx) and related dry skin disorders | MAZZIO ELIZABETH ANNE | 2010-02-23 | — | — | US | claimed |
| US-7357950-B2 | Topical treatment for dyshidrosis (pompholyx) and dry skin disorders | MAZZIO ELIZABETH ANNE | 2008-04-15 | — | — | US | claimed |
| US-11852970-B2 | Material for lithography, production method therefor, composition for lithography, pattern formation method, compound, resin, and method for purifying the compound or the resin | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2023-12-26 | — | — | US | disclosed |
| US-11480877-B2 | Resist composition, method for forming resist pattern, and polyphenol compound used therein | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2022-10-25 | — | — | US | disclosed |
| CN-114555619-A | Compounds and compositions for differential modulation of nicotinamide adenine dinucleotide | 麦德龙国际生物科技有限责任公司 | 2022-05-27 | — | — | CN | disclosed |
| CN-114235986-A | High performance liquid chromatography detection method for contents of vitamins B1, B2, B6, nicotinic acid and nicotinamide | 浙江艾兰得生物科技有限公司 | 2022-03-25 | — | — | CN | disclosed |
| US-11256170-B2 | Compound, resist composition, and method for forming resist pattern using it | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2022-02-22 | — | — | US | disclosed |
| CN-111272912-B | Method for measuring nicotinic acid and nicotinamide in infant rice flour by solid-phase extraction-high performance liquid chromatography | 山东省食品药品检验研究院 | 2022-02-01 | — | — | CN | disclosed |
| US-20210121469-A1 | Edible Energy Composition | INTERNATIONAL IP HOLDINGS LLC (US) | 2021-04-29 | — | — | US | disclosed |
| US-20210077517-A1 | Edible Energy Composition | International IP Holdings (US) | 2021-03-18 | — | — | US | disclosed |
| EP-1706131-A2 | HELICAL SYNTHETIC PEPTIDES THAT STIMULATE CELLULAR CHOLESTEROL EFFLUX | The Regents of the University of California (US) | 2006-10-04 | — | — | EP | disclosed |
| WO-2005058938-A2 | HELICAL SYNTHETIC PEPTIDES THAT STIMULATE CELLULAR CHOLESTEROL EFFLUX | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2005-06-30 | — | — | WO | disclosed |
| EP-1469746-A2 | MODULAR SYSTEM OF DIETARY SUPPLEMENT COMPOSITIONS COMPRISING VITAMINS | Meijer, Jaap (NL) | 2004-10-27 | — | — | EP | disclosed |
| CN-1447680-A | Local release system of micronutrients and application thereof | NIADYNE CORP (US) | 2003-10-08 | — | — | CN | disclosed |
| WO-2002076436-A2 | MODULAR SYSTEM OF DIETARY SUPPLEMENT COMPOSITIONS COMPRISING VITAMINS | MEIJER JAAP (NL) | 2002-10-03 | — | — | WO | disclosed |
| EP-0938605-A1 | ENZYMATIC METHOD FOR OVERDYEING CELLULOSIC TEXTILES | Novo Nordisk Biochem North America, Inc. (US) | 1999-09-01 | — | — | EP | disclosed |
| WO-1998005816-A1 | ENZYMATIC METHOD FOR OVERDYEING CELLULOSIC TEXTILES | NOVO NORDISK BIOCHEM NORTH AMERICA, INC. (US) | 1998-02-12 | — | — | WO | disclosed |
| EP-0662818-A1 | COSMETIC COMPOSITION CONTAINING RETINOL | UNILEVER PLC (GB) | 1995-07-19 | — | — | EP | disclosed |
| WO-1994007462-A1 | COSMETIC COMPOSITION CONTAINING RETINOL | UNILEVER PLC (GB) | 1994-04-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11480877-B2 | Resist composition, method for forming resist pattern, and polyphenol compound used therein | SLC11A2, ABCC1, FBL | F7 2558/4885F3 3261/4885SARM1 4289/4885 |
| US-11852970-B2 | Material for lithography, production method therefor, composition for lithography, pattern formation method, compound, resin, and method for purifying the compound or the resin | SLC39A11, CROCC, TERB1 | F7 276/4885F3 1179/4885SARM1 3538/4885 |
| US-11256170-B2 | Compound, resist composition, and method for forming resist pattern using it | RDX, SLC11A2, FBL | F7 1629/4885F3 2060/4885SARM1 2822/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.